Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1

Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0-10.0 ng ml−1 , however, it remains controversial whether %fPSA is effective in PSA range of 10.1-20.0 ng ml−1 in both Chinese and Western population....

Description complète

Détails bibliographiques

Auteurs principaux:	Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2015-01-01
Collection:	Asian Journal of Andrology
Sujets:	Chinese population; diagnosis; percent free prostate-specific antigen; prostate cancer; prostate carcinoma tumor antigen; prostate-specific antigen
Accès en ligne:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=6;spage=1017;epage=1021;aulast=Chen
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!